Home » FDA Approves First Cannabis-Based Drug for Treating Epileptic Seizures
FDA Approves First Cannabis-Based Drug for Treating Epileptic Seizures
Drugs Regulatory Affairs
The FDA approved Epidiolex (cannabidiol) for treating seizures associated with two rare and severe forms of epilepsy, marking the country’s first agency approval of a cannabis-based drug.
Epidiolex is also the first FDA approved drug for treating patients with Dravet syndrome, a rare genetic condition that typically appears during the first year of life and causes prolonged and frequent seizures, as well as developmental issues in the patient.
“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said FDA Commissioner Scott Gottlieb.